Diet Coke Resolves Stomach Blockage Linked to Ozempic Use in Massachusetts Patient
A 63-year-old woman in Massachusetts avoided surgery after doctors used something surprising to treat her: diet soda. The woman,…
A 63-year-old woman in Massachusetts avoided surgery after doctors used something surprising to treat her: diet soda. The woman,…
National poison control centers reported a significant increase in calls related to glucagon-like peptide-1 receptor agonists. This surge followed…
Scientists use artificial intelligence to create new peptide candidates and predict specific peptide properties. Combining these two abilities in…
Demand for GLP-1 receptor agonists has grown beyond traditional clinical settings. Patients now seek these medications through online marketplaces,…
Eli Lilly wrapped up the first quarter of 2026 in a strong position, showcasing solid financial results alongside two…
New research shows that women who use glucagon-like peptide-1 receptor agonists see measurable benefits in the job market. Harvard…
Organizations are still facing the significant financial challenges posed by GLP-1 receptor agonist medications. Recent survey data shows that…
The GLP-1 receptor agonist class started when national regulators approved exenatide for diabetes management. Researchers first developed these molecules…
Starting July 1, 2026, millions of older Americans will be able to access popular GLP-1 weight-loss medications for just…
Physicians are prescribing GLP-1 receptor agonists to children under twelve, despite the lack of specific federal approval. The Food…